Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis

被引：37

作者：

Spadaro, A. ^{[1
]}

Ceccarelli, F. ^{[1
]}

Scrivo, R. ^{[1
]}

Valesini, G. ^{[1
]}

机构：

[1] Univ Rome, Dipartimento Clin & Terapia Med, Rheumatol Unit, I-00161 Rome, Italy

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2008年 / 67卷 / 11期

关键词：

D O I：

10.1136/ard.2007.085951

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1650 / 1651

页数：4

共 11 条

[1] Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis - A Department of Veterans Affairs cooperative study [J].

Clegg, DO ;

Reda, DJ ;

Mejias, E ;

Cannon, GW ;

Weisman, MH ;

Taylor, T ;

BudimanMak, E ;

Blackburn, WD ;

Vasey, FB ;

Mahowald, ML ;

Cush, JJ ;

Schumacher, HR ;

Silverman, SL ;

Alepa, FP ;

Luggen, ME ;

Cohen, MR ;

Makkena, R ;

Haakenson, CM ;

Ward, RH ;

Manaster, BJ ;

Anderson, RJ ;

Ward, JR ;

Henderson, WG .

ARTHRITIS AND RHEUMATISM, 1996, 39 (12) :2013-2020

[2]

HELLIWELL P, 1991, BRIT J RHEUMATOL, V30, P339

[3] Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis - Results from the British Society for Rheumatology Biologics Register [J].

Hyrich, Kimme L. ;

Symmons, Deborah P. M. ;

Watson, Kath D. ;

Silman, Alan J. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (06) :1786-1794

[4]

Kavanaugh A, 2006, CURR OPIN RHEUMATOL, V18, P347

[5]

KRISTENSEN LE, ANN RHEUM DIS, DOI DOI 10.1136/ARD.2007.073544

[6] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[7]

Maini RN, 1998, ARTHRITIS RHEUM, V41, P1552, DOI 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO

[8]

2-W

[9] A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis [J].

Ravindran, V. ;

Scott, D. L. ;

Choy, E. H. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (06) :855-859

[10] Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis - Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial [J].

van der Heijde, D ;

Klareskog, L ;

Rodriguez-Valverde, V ;

Codreanu, C ;

Bolosiu, H ;

Melo-Gomes, J ;

Tornero-Molina, J ;

Wajdula, J ;

Pedersen, R ;

Fatenejad, S .

ARTHRITIS AND RHEUMATISM, 2006, 54 (04) :1063-1074

← 1 2 →